Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08FWJ
|
|||
| Drug Name |
GSK3377794
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1], [2] | |
| Merkel cell carcinoma [ICD-11: 2C34; ICD-10: C44] | Phase 2 | [1], [2] | ||
| Multiple myeloma [ICD-11: 2A83; ICD-10: C90.0] | Phase 2 | [1] | ||
| Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 2 | [1] | ||
| Synovial sarcoma [ICD-11: 2B5A; ICD-9: 171] | Phase 2 | [1] | ||
| Company |
GlaxoSmithKline Research Triangle Park, NC
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.